Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, α-interferon, cisplatin (FAP)

Shi Ming Tu, Randall E. Millikan, Lance C. Pagliaro, Danai Daliani, Christos N. Papandreou, Jeri Kim, Dung Tsa Chen, Dallas L. Williams, Christopher J. Logothetis

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint Dive into the research topics of 'Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, α-interferon, cisplatin (FAP)'. Together they form a unique fingerprint.

Medicine & Life Sciences